About
Focus
Pipeline
Patients
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Focus
Pipeline
Patients
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
Clinical Immunology Society (CIS) Annual Meeting / European Hematology Association (EHA) Annual Congress
Clinical Immunology Society (CIS) Annual Meeting / European Hematology Association (EHA) Annual Congress
June 2023
Results of a Phase 3 Trial of an Oral CXCR4 Antagonist, Mavorixafor, for Treatment of Patients with WHIM Syndrome
© 2023 X4 Pharmaceuticals, Inc. All rights reserved.
Terms of Use
|
Privacy Policy